Resveratrol and Red Wine Extracts Inhibit the Growth of CagA؉ Strains of Helicobacter pylori In Vitro
TO THE EDITOR: In 1994, Helicobacter pylori was classified as a group I carcinogen and a definite cause of gastric cancer in humans by the International Agency for Research on Cancer (1). Since then, H. pylori has been epidemiologically linked to adenocarcinoma of the distal stomach (2, 3) , and a recent study has also found a positive association between H. pylori infection and colorectal adenomas (4) . CagA is the strain-specific H. pylori gene that has been linked to the development of premalignant and malignant histological lesions (5) . Thus, susceptibility of cagAϩ H. pylori strains is of note because, as compared with cagAϪ strains, infections caused by cagAϩ strains significantly increase the risk for developing severe gastric inflammation, atrophic gastritis, and noncardia gastric adenocarcinoma (5) . Previously, we have demonstrated that resveratrol, a stilbene from red wine, inhibited the growth of 15 clinical strains of H. pylori in vitro and suggested that the anti-H. pylori activity of resveratrol may play a role in its chemopreventative effects (6) . In this investigation, the antibacterial activities of two red wine extracts (Pinot Noir) and resveratrol were assessed against five cagAϩ H. pylori strains: accession numbers M23-3, GTD7-13, G1-1, SS1 (Sydney Strain cagAϩ), and the ATCC 43504 (Rockville, MD) possessing the cagAϩ gene and expressing vacuolating cytotoxin. The H. pylori cagAϩ strains were obtained from Drs. Richard Peek and Dawn Israel, Department of Pathology, Vanderbilt University School of Medicine, Nashville, TN. Susceptibility testing was performed with the agar dilution procedure, and all other methods were as previously described (6) . Red wine extracts (Pinot Noir) were prepared, one by concentrating and drying under reduced pressure, and the second by separating the alcoholsoluble and -insoluble components. The second extract was prepared by dissolving 1500 ml of red wine in 3 L of methanol, concentrating under reduced pressure, filtering, and collecting both the filtrate (alcohol soluble) and the particulate matter (alcohol insoluble). The filtrate was termed a methanol-soluble extract, and the particulate matter was termed a methanol-insoluble extract. The methanolsoluble extract was not active in our assay at concentrations up to 500 g/ml. However, both the methanol-insoluble and the concentrated red wine extracts were active against all cagAϩ HP strains, with minimum inhibitory concentrations (MIC) of 25 g/ml and 50 g/ml, respectively (range of 25-50 g/ml). Resveratrol was also active against all five strains, with an MIC of 12.5 g/ml (range of 6.25-25 g/ml). The control drug, amoxicillin, had an MIC range of 0.0039 to 0.25 g/ml. These data demonstrate that both red wine and resveratrol inhibit the growth of H. pylori cagAϩ strains in vitro and further support their role as chemopreventive agents.
Pyopneumopericardium Due to an Esophagopericardial Fistula With a Fish Bone
TO THE EDITOR: Esophagopericardial fistula is a rare complication of both benign and malignant esophageal diseases. Because it is often associated with extremely high mortality rates (1), early recognition and proper therapy by pericardial drainage and operative closure of the fistula are paramount for the successful management of esophagopericardial fistula. Here we report on a patient who had a vague medical history and nonspecific chest pain, in whom a diagnosis of pyopneumopericardium after esophagopericardial fistula with a fish bone was made by echocardiography, CT of the chest, and upper GI endoscopy; the fistula was treated surgically.
A 40-yr-old Asian man presented with complaints of chest pain and dyspnea. He had a history of duodenal ulcer. He denied dysphagia or odynophagia. Physical examination revealed an acutely ill appearance, with a temperature of 38.4°C, tachycardia (100 -120 beats/min), tachypnea (20 -25/min), and a systolic blood pressure of 110 mm Hg. His breathing was clear, and cardiac auscultation revealed no murmur. Admission laboratory tests gave the following results: white cell count 15,000/dl (normal: 4,000 -10,000/ dl), Hb 12.5 g/dl (13.5-18.0 g/dL), platelet count 264,000/dl (150,000 -400,000/dl), BUN 25 mg/dl (5-25 mg/dl), and creatinine 0.5 mg/dl (0.7-1.4 mg/dl). An electrocardiogram demonstrated normal sinus rhythm with diffuse S-T elevation and normal voltage in all precordial leads, which suggested acute pericarditis. There was no abnormal finding on the first echocardiography. On the third hospital day, plain radiographs of the chest revealed an enlarged cardiac silhouette with bilateral pleural effusions, and two-dimensional echocardiogram at that time clearly confirmed the presence of the pericardial effusion and air bubble. CT of the chest confirmed the presence of pneumopericadium with impacted foreign body in the lateral wall of the lower esophagus (Fig. 1) . The patient immediately underwent esophagoscopy, which revealed a deep white ulcer of 1 cm diameter on the esophagus, 38 cm from the incisors (Fig. 2) . The patient underwent emergency surgery. Through a left thoracostomy, a 2-cm-long fish bone that was stuck in the pericardium and into the pericardial cavity was removed. The postoperation course of the patient was uneventful. The patient was discharged from the hospital completely well.
Esphagopericardial fistula is uncommon and associated with both benign and malignant diseases. Benign conditions, such as esophageal ulcers, reflux esophagitis, foreign body ingestion, iatrogenic injury, tuberculosis, esophageal diverticula, achalasia, and Barrett's esophagus constitute 77% of esphagopericardial fistulae; 23% are due to malignancies of the esophagus (2, 3). Perforation of the esophagus adjacent to the cardiovascular system can involve the pericardium and can result in death from sepsis, cardiac tamponade, or massive hemorrhage subsequent to atrial or ventricular perforation. In an earlier report of esophagopericardial fistula, the history, review of systems, findings on physical examination, and initial invasive and noninvasive studies suggested only congestive heart failure (2) . In situations such as this, exact diagnosis of esophagopericardial fistula could be delayed. Because our patient had no distinct medical history of ingesting fish bones and no specific symptoms (e.g., odynophagia and dysphagia), we did not suspect esophageal injury at admission and did not perform esophagoscopy early. Esophagoscopy was performed after the pericardial effusion on echocardiography and the foreign body on CT scan were demonstrated.
